TABLE OF CONTENTS
Volume 66, Issue S90 (September 2004)
Top of page
Original Articles
Introduction FREE
WAJEH Y QUNIBI
Kidney Int 66: S1-S2; doi:10.1111/j.1523-1755.2004.09001.x
Projecting the United States ESRD population: Issues regarding treatment of patients with ESRD FREE
LYNDA ANNE SZCZECH and IRA L LAZAR
Kidney Int 66: S3-S7; doi:10.1111/j.1523-1755.2004.09002.x
Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD) FREE
WAJEH Y QUNIBI
Kidney Int 66: S8-S12; doi:10.1111/j.1523-1755.2004.09004.x
The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification FREE
ALLEN C ALFREY
Kidney Int 66: S13-S17; doi:10.1111/j.1523-1755.2004.09003.x
Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor? FREE
PETER A MCCULLOUGH and SANDEEP SOMAN
Kidney Int 66: S18-S24; doi:10.1111/j.1523-1755.2004.09008.x
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure FREE
MICHAEL EMMETT
Kidney Int 66: S25-S32; doi:10.1111/j.1523-1755.2004.09005.x
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: Results of the CARE study FREE
WAJEH Y QUNIBI and CHARLES R NOLAN
Kidney Int 66: S33-S38; doi:10.1111/j.1523-1755.2004.09006.x
Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications FREE
BARTON BREZINA, WAJEH Y QUNIBI and CHARLES R NOLAN
Kidney Int 66: S39-S45; doi:10.1111/j.1523-1755.2004.09007.x
